QA: Lexaria Bioscience Corp in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001348362_2026_Lexaria_Bioscience_Corp.pdf

Logs

Graph

Absolute values for 0001348362, Lexaria Bioscience Corp

  xvar xval
0 AssetsCurrent 3,468,345
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 228,129
3 remainder_Assets 478,647
4 LiabilitiesCurrent 1,493,463
5 LiabilitiesNoncurrent 78,903
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 2,435
8 SellingGeneralAndAdministrativeExpense 4,341,963
9 ResearchAndDevelopmentExpense 2,377,827
10 remainder_Expenses 0
11 remainder_Revenues 659,683
12 remainder_NetIncome -37,887
13 remainder_ComprehensiveNetIncome -42,612
  yvar yval
0 Assets 4,175,121
1 Liabilities 1,572,366
2 Expenses 6,722,225
3 Revenues 659,683
4 StockholdersEquity 2,602,755
5 NetIncome -6,100,429
6 ComprehensiveNetIncome -6,121,735
7 BaseVar 6,604,947
8 EconomicCapitalRatiobeforeLimitedLiability -0.156
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time